The course of Semliki Forest virus (SFV) A7(74) infection in immunocompetent BALB/c, athymic nu/nu and severe combined immunodeficient (SCID) mice was compared. BALB/c mice remained healthy and exhibited transient viraemia and infectious virus in the brain from days 2 to 7. Antibodies were detectable by day 5. In comparison, SCID mice displayed a high incidence of paralysis and died: the average day of death was day 23. From infection until death, virus was present in blood and brain. No antibodies were detectable. Athymic mice were intermediate with a transient viraemia and a persistent (> 210 days) sub-clinical central nervous system (CNS) infection. These mice produced anti-viral IgM but not IgG. The pattern of infection in BALB/c or nu/nu mice could be recreated in infected SCID mice by transfer of immune serum from BALB/c or nu/nu mice, with the important exception that although BALB/c immune serum could abolish infectivity titres in the CNS, scattered cells positive for viral RNA remained. Transfer of serum decreased mortality and delayed the onset of paralysis. Transfer to infected SCID mice of a non-neutralizing IgG anti-E2 monoclonal antibody did not affect the viraemia but could also reduce brain virus titres. Irrespective of specific immune responses, virus replication in CNS cells was restricted, was generally non-cytopathic and in the absence of specific immune responses could persist. From day 14 lesions of inflammatory, primary demyelination were observed throughout the CNS of BALB/c mice. In contrast, despite prolonged brain virus titres, no demyelinating lesions were observed in infected nu/nu or SCID mice. Lesions could be initiated in the latter by transfer of spleen cells but not antibody. In summary, the focal restricted infection in the CNS of adult mice infected with SFV A7(74) is independent of specific immune responses. IgM antibodies clear the viraemia. IgG antibodies including non-neutralizing antibodies reduce and clear infectious virus but cells positive for viral RNA remain. These may normally be cleared by T cell responses which are damaging and give rise to lesions of demyelination.
BancroftG. J.,
SheehanK. C. F.,
SchreiberR. D.,
UnanueE. R.1987; A T cell-independent mechanism of macrophage activation by interferon-gamma. Journal of Immunology 139:1104–1107
BancroftG. J.,
SchreiberR. D.,
BosmaG. C.,
BosmaM. J.,
UnanueE. R.1989; Tumor necrosis factor is involved in the T-cell independent pathway of macrophage activation by interferongamma. Journal of Immunology 143:127–130
BarrettA. D. T.,
CrossA. J.,
CrowP. J.,
JohnsonJ. A.,
GuestA. R.,
DimmockN. J.1986; Subclinical infection in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system. Journal of General Virology 67:1727–1732
BergerM. L.1980; Humoral and cell mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis. Infection and Immunity 30:244–253
BuchmeierM. J.,
LewickiH. A.,
TalbotP. J.,
KnoblerR. L.1984; Murine hepatitis virus-4 (strain JHM)-induced neurological disease is modulated in vivo by monoclonal antibody. Virology 132:261–270
ChowL. H.,
BeiselK. W.,
McManusB. M.1992; Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Laboratory Investigation 66:24–31
FazakerleyJ. K.,
WebbH. E.1987a; Semliki Forest virus induced, immune mediated demyelination: the effects of irradiation. British Journal of Experimental Pathology 68:101–113
FazakerleyJ. K.,
WebbH. E.1987b; Semliki Forest virus induced, immune mediated demyelination: adoptive transfer studies and viral persistence in nude mice. Journal of General Virology 68:377–385
FazakerleyJ. K.,
AmorS.,
WebbH. E.1983; Reconstitution of Semliki Forest virus infected mice, induces immune mediated pathological changes in the CNS. Clinical and Experimental Immunology 52:115–120
FazakerleyJ. K.,
PathakS.,
ScallanM.,
AmorS.,
DysonH.1993; Replication of the A7(74) strain of Semliki Forest virus is restricted to neurons. Virology 195:627–637
FujinamiR. S.,
RosenthalA.,
LampertP. W.,
ZurbriggenA.,
YamadaM.1989; Survival of athymic (nu/nu) mice after Theiler’s murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. Journal of Virology 63:2081–2087
JagelmanS.,
SucklingA. J.,
WebbH. E.,
BowenE. T. W.1978; The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice. Journal of General Virology 41:599–607
KellyW. R.,
BlakemoreW. F.,
JagelmanS.,
WebbH. E.1982; Demyelination induced in mice by avirulent Semliki Forest virus. Part 2. An ultrastructural study of focal demyelination in the brain. Neuropathology and Applied Neurobiology 2:43–53
KimM. G.,
SchulerW.,
BosmaM. J.,
MarcusK. B.1988; Aberrant Igh locus rearrangements in A-MuLV pre B lines of scid mice: evidence for deregulated D-J recombination. Current Topics in Microbiology and Immunology 137:203–210
KurtzC. I. B.,
SunX. M.,
FujinamiR. S.1995; Protection of SJL/J mice from demyelinating disease mediated by Theiler’s murine encephalomyelitis virus. Microbial Pathogenesis 18:11–27
LevineB.,
HardwickJ. M.,
TrappB. D.,
CrawfordT. O.,
BollingerR. C.,
GriffinD. E.1991; Antibody-mediated clearance of alphavirus infection from neurons. Science 254:856–860
LevineB.,
HuangQ.,
IsaacsJ. T.,
ReedJ. C.,
GriffinD. E.,
HardwickJ. M.1993; Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739–742
LiebertU. G.,
Schneider-SchauliesS.,
BaczkoK.,
ter MeulenV.1990; Antibody-induced restriction of viral gene expression in measles encephalitis in rats. Journal of Virology 64:706–713
LipkinW. I.,
BattenbergE. L. F.,
BloomF. E.,
OldstoneM. B. A.1988; Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury. Brain Research 451:333–339
MalynnB. A.,
BlackwellT. K.,
FulopG. M.,
RathbunG. A.,
FurleyA. J. W.,
FerrierP.,
HeinkeB.,
PhillipsR. A.,
YancopoulosG. D.,
AltF. W.1988; The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 54:453–460
MehtaS.,
ParsonsL. M.,
WebbH. E.1993; Effect of amitriptyline on neurotransmitter levels in mice following infection with the avirulent strain of Semliki Forest virus. Journal of Neurological Sciences 116:110–116
PathakS.,
WebbH. E.,
OatenS. W.,
BatemanS.1976; An electron-microscopic study of the development of virulent and avirulent strains of Semliki Forest virus in mouse brain. Journal of Neurological Sciences 28:289–300
PathakS.,
WebbH. E.1978; An electron-microscopic study of avirulent and virulent Semliki Forest virus in the brains of different ages of mice. Journal of Neurological Sciences 39:199–211
PathakS.,
WebbH. E.1980; The entry and the transport of arboviruses into and throughout mouse brain: an electron- microscopic study. Electron Microscopy 2:492–493
PusztaiR.,
GouldE.,
SmithH.1971; Infection pattern in mice of an avirulent and virulent strain of Semliki Forest virus. British Journal of Experimental Pathology 52:669–677
RozengurtN.,
SanchezS.1993; A spontaneous outbreak of Theiler’s encephalomyelitis in a colony of severe combined immunodeficient mice in the UK. Laboratory Animals 27:229–234
SchulerW.,
WeilerI. J.,
SchulerA.,
PhillipsR. A.,
RosenbergN.,
MakT. W.,
KearneyJ. F.,
PerryR. P.,
BosmaM. J.1986; Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46:963–972
SimasJ. P.,
DysonH.,
FazakerleyJ. K.1995; Molecular analysis of persistence, tropism and genetic variability of the BeAn strain of Theiler’s virus in the mouse CNS. Journal of Virology 69:5599–5606
Subak-SharpeL.,
DysonH.,
FazakerleyJ. K.1993; In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. Journal of Virology 67:7629–7633
SucklingA. J.,
PathakS.,
JagelmanS.,
WebbH. E.1978; Virus associated demyelination: a model using avirulent Semliki Forest virus infection of mice. Journal of Neurological Sciences 36:147–154
TylerK. L.,
VirginH. W.,
Bassel-DubyR.,
FieldsB. N.1989; Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. Journal of Experimental Medicine 170:887–900
WherryJ. C.,
SchriberR. D.,
UnanueE. R.1991; Regulation of gamma interferon production by natural killer cells in scid mice: role of tumor necrosis factor and bacterial stimuli. Infection and Immunity 59:1709–1715